---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-22-000048"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2022-06-01T23:59:59+00:00"
generated_at: "2026-06-25T05:27:06.333228+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CV Sciences stockholders approve 4x share increase, reverse split up to 1:400; Board reduced to 3

## Summary
- Stockholders elected Dr. Joseph Maroon and Joseph Dowling as directors; 3 prior directors did not stand for re-election.
- Authorized shares increased from 200M to 800M; common stock authorized from 190M to 790M.
- Reverse stock split approved (1:10 to 1:400), at Board discretion before May 30, 2025.
- Board size reduced to 3 members to cut costs, leaving one vacancy.
- Ratification of Haskell & White as auditor for FY2022 passed; advisory vote on executive comp approved.

## SEC filing metadata
- accession: 0001510964-22-000048
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2022-06-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/0001510964-22-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000048/cvsi-20220526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-22-000048
- JSON: https://secwatch.observer/filing/0001510964-22-000048.json
- Plain text: https://secwatch.observer/filing/0001510964-22-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.